Search Share Prices
HIK Shares - Hikma Pharmaceuticals’ (HIK) “Overweight” Rating Reaffirmed at Barclays
Barclays restated their overweight rating on shares of Hikma Pharmaceuticals (LON:HIK – Get Rating) in a research note published on Monday morning, Price Targets.com reports. The firm currently has a ...
Hikma Pharmaceuticals (LON:HIK) Rating Lowered to Equal Weight at Morgan Stanley
Hikma Pharmaceuticals (LON:HIK – Get Rating) was downgraded by Morgan Stanley to an “equal weight” rating in a report issued on Thursday, PriceTargets.com reports. They presently have a GBX 2,300 ($30 ...
Hikma Pharmaceuticals (LSE:HIK)
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of ...
Analysts Have Made A Financial Statement On Hikma Pharmaceuticals PLC's (LON:HIK) Yearly Report
Hikma Pharmaceuticals PLC (LON:HIK) came out with its yearly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following ...
Analysts Have Made A Financial Statement On Hikma Pharmaceuticals PLC's (LON:HIK) Yearly Report
Hikma Pharmaceuticals PLC ( LON:HIK ) came out with its yearly results last week, and we wanted to see how the ...